Stephen T. Worland

EVP, Pharmaceuticals, ANADYS PHARMACEUTICALS INC.

Companies

eFFECTOR Therapeutics, Inc.Board member Aug 27, 2021 to May 17, 2024¹
eFFECTOR Therapeutics, Inc.Chief executive officer Aug 27, 2021 to May 17, 2024¹
Tracon Pharmaceuticals, Inc.Board member Feb 27, 2015 to Apr 21, 2023²
eFFECTOR Therapeutics, Inc.President Aug 27, 2021 to Jun 22, 2022¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

May 15, 2024Granted 1,806 shares at $1.68 of eFFECTOR Therapeutics, Inc.³
Nov 15, 2023Granted 5,979 shares at $0.50 of eFFECTOR Therapeutics, Inc.⁴
Aug 11, 2023Exercised options 33,799 shares at $0.52 of eFFECTOR Therapeutics, Inc.⁵
May 15, 2023Granted 6,401 shares at $0.46 of eFFECTOR Therapeutics, Inc.⁶
Nov 15, 2022Granted 6,047 shares at $0.47 of eFFECTOR Therapeutics, Inc.⁷
Jun 7, 2022Bought 20,000 shares at $1.37 of eFFECTOR Therapeutics, Inc.⁸
May 13, 2022Granted 1,837 shares at $1.53 of eFFECTOR Therapeutics, Inc.⁹

The numbers on this page point here. Each one links to the record it came from.